Timothy D. Mikulski

Timothy D. Mikulski

Auto-generated profile, based on publicly available information

Timothy D. Mikulski

Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 January 2022 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
BWBenjamin Williamson
Benjamin Williamson
AWAdam Wilk
Adam Wilk
KGKevin D. Guerrero
Kevin D. Guerrero
TMTimothy D. Mikulski
Timothy D. Mikulski
TETony N. Elias
Tony N. Elias
KHKelley Healey
Kelley Healey
ERG11 sequencing of 28 Candida auris clade III isolates revealed the presence of concomitant V125A and F126L substitutions. Heterologous expression of Erg11-V125A/F126L in Saccharomyces cerevisiae led to reduced fluconazole and voriconazole susceptibilities.